Organigram Global (OGI) Change in Acquisitions & Divestments (2018 - 2026)
Organigram Global (OGI) posted quarterly Change in Acquisitions & Divestments of $591.4 million for Q1 2026, down 2.8% year-over-year from $608.4 million in Q1 2025, and up 99743.42% quarter-over-quarter from $592313.3 in Q4 2025.
Organigram Global (OGI) Change in Acquisitions & Divestments (2018 - 2026) Analysis & Trends
Organigram Global (OGI) has reported Change in Acquisitions & Divestments for 7 consecutive years, with $591.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Acquisitions & Divestments fell 2.8% year-over-year to $591.4 million; the TTM figure through Mar 2026 stood at $1.2 billion (down 88.57% YoY), while the FY2021 annual figure was $60.0 million, changed N/A from the prior year.
- Change in Acquisitions & Divestments climbed to $591.4 million in Q1 2026 per OGI's latest filing, from $592313.3 in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $608.4 million in Q1 2025 and bottomed at -$1.2 million in Q4 2024.
- Historically, Change in Acquisitions & Divestments has averaged $299.8 million across 3 years, with a median of $296.0 million in 2026.
- Annual changes were most pronounced in 2025 — Change in Acquisitions & Divestments jumped 149.88% — and 2026, when it retreated 2.8%.
- Organigram Global's Change in Acquisitions & Divestments stood at -$1.2 million in 2024, then surged by 149.88% to $592313.3 in 2025, then surged by 99743.42% to $591.4 million in 2026.
- Business Quant data shows OGI's Change in Acquisitions & Divestments at $591.4 million in Q1 2026, $592313.3 in Q4 2025, and $608.4 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - |
| 10 | Organigram Global | 151.29 Mn | 151.17 Mn | 28.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 591.39 Mn |
| Mar 31, 2026 | 591.39 Mn |
| Dec 31, 2025 | 592,313.27 |
| Dec 31, 2025 | 592,313.27 |
| Mar 31, 2025 | 608.41 Mn |
| Mar 31, 2025 | 608.41 Mn |
| Dec 31, 2024 | -1.19 Mn |
| Dec 31, 2024 | -1.19 Mn |
| May 31, 2021 | -120.02 Mn |
| May 31, 2021 | -120.02 Mn |
| Feb 28, 2021 | 10.00 Bn |
| Feb 28, 2021 | 10.00 Bn |
| Nov 30, 2020 | 30.00 Bn |
| Nov 30, 2020 | 30.00 Bn |
| May 31, 2020 | 97.25 |
| May 31, 2020 | 97.25 |
| Feb 29, 2020 | 134,824.00 |
| Feb 29, 2020 | 134,824.00 |
| Aug 31, 2019 | 380.00 |
| Aug 31, 2019 | 380.00 |